Menu
Washingtoner
  • Home
  • Home
  • Business
  • Financial
  • Information Technology
  • Crypto
  • Construction
  • Fitness
  • Marketing
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm
  • Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
  • Hyatt House Fresno Celebrates Grand Opening, Introducing the First Hyatt House in Fresno, California
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Tacoma: City Council Adopts Community Safety Action Strategy Built on Community Input
  • City Council Adopts 'Tacoma 2035'
  • Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
  • City of Spokane Prepared for Forecasted Winds
  • A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
  • Children Rising Appoints Marshelle A. Wilburn as New Executive Director
  • Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
  • Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
  • Bent Danholm Joins The American Dream TV as Central Florida Host
  • The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
  • Artificial Intelligence Leader Releases Children's Book on Veterans Day
  • Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
  • CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
  • Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
  • MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
  • From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
  • New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
  • UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
  • Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
  • South Spokane Burglary Suspect Quickly Taken Into Custody; Suspect Found Sitting in a Chair When Officers Arrived
  • Spokane City Council Approves Special Revenue Fund Projects Encouraging Safe Driving
_catLbl0 _catLbl1

Popular on Washingtoner

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 1286
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
  • Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
  • Cut Costs & Boost Profits with the First Major Upgrade in 30 YEARS Replacing Rotary Lasers and Historic Clear Tube Altimeter Bubbles
  • City of Spokane Funds 50 New Shelter Beds, Mobile Medication Assisted Treatment Services
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
  • TownePlace Suites Prescott Valley, AZ Opens
  • Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand

Similar on Washingtoner

  • Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
  • NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
  • VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
  • Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
  • CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
  • From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
  • New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
  • Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
  • Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
  • Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute